Sep 08, 2021 / NTS GMT
Garo H. Armen - Protagenic Therapeutics, Inc. - Co-Founder & Executive Chairman of the Board
All right, I'm thanking you all for joining us today. Today is the PTI Science and Clinical Review. With me are Professor David Lovejoy, who is the scientific founder of PTI. He will tell us about his personal journey that led him to the discovery of TCAP. And we'll tell you a little bit about TCAP because it is a very exciting new class of compound and the role that -- the critical role that TCAP plays in stress response, which is, as you know, an ever-growing epidemic in today's world and with many, many challenges.
After Professor David Lovejoy will be Dr. Andy Slee, who is the Chief Operating Officer of PTI. Andy is a world-class pharmacologist in addition to all of his other talents, particularly with substantial experience in neurosciences. He will tell us about his journey of taking David Lovejoy's results with a skeptical eye in the beginning and studying a multitude of disease models, having left no stones unturned in his attempt to validate TCAP's role.
After Dr. Slee will be Dr. Jen
Protagenic Therapeutics Inc Science Review (Virtual) Transcript
Mar 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers